ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
3,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
8,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
8,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
9,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
13,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
13,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
15,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
15,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
17,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
19,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
19,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
20,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
20,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
20,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
20,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
20,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
21,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
23,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
24,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
25,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
25,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
27,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
27,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
28,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
29,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
29,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
31,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
31,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
31,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
33,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
34,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
34,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
35,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
36,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
37,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
37,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
37,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
38,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
38,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
38,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
39,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
40,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
41,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
42,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
43,1,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
44,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
45,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
47,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
48,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
49,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
50,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
51,2,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
52,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
53,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
53,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
54,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
55,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
56,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
57,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
57,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
57,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
58,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
58,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
60,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
61,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
62,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
63,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
63,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
63,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
64,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
64,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
64,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
65,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
66,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
67,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
68,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
68,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
68,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
68,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
68,5,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
69,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
73,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
73,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
73,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
74,2,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
75,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
76,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
76,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
78,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
78,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
78,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
78,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
79,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
80,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,Y
81,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
82,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
83,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
84,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
85,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
86,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
86,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
87,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
88,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
89,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
90,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
92,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
93,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
94,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
95,1,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
95,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
96,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
97,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
97,2,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
98,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
99,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
100,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
101,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
102,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
103,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
104,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
104,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
104,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
105,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
106,2,Retinal dystrophy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
107,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
109,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
110,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
111,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
112,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
113,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
115,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
116,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
116,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
117,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
117,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
118,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
119,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
120,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
121,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
121,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
121,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
121,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
122,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
122,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
122,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
122,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
122,6,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
123,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
124,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
125,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
126,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
127,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
128,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
129,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
131,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
132,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
133,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
134,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
135,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
136,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
137,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
138,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
139,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
140,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,Y
141,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
143,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
143,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,Y
145,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
146,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
146,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
147,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
148,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
150,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
151,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
152,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
152,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
152,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
153,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
154,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
154,2,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
154,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
155,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
157,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
158,1,Testicular failure primary,Male gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
159,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
159,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
159,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
160,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
161,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
162,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
163,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
164,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
165,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
165,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
166,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
166,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
167,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
168,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
170,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
172,1,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
173,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
174,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
174,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
175,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
176,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
177,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
178,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
179,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
180,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
181,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
182,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
183,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
183,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
183,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
184,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
184,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
184,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
184,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
184,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
184,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
184,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
185,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
186,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
186,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
187,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
187,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
188,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,3,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
189,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
190,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
191,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
191,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
191,3,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
192,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
193,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
194,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
194,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
195,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
195,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
196,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
197,1,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
197,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
197,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
197,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
199,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
200,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
201,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
202,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
203,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
204,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
204,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
206,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
206,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
207,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
208,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
208,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
210,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
211,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
212,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
212,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
213,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
213,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
214,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
214,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
214,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
215,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
216,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
217,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
218,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
219,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
220,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
221,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,Y
222,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
223,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
225,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
226,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
227,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
227,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
228,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
228,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
229,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
230,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
230,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
230,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
231,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
231,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
231,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
231,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
231,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
232,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
232,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
233,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
234,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
235,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
237,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
237,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
238,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
239,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
240,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
241,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
241,2,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
242,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
242,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
243,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
244,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
244,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
245,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
246,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
247,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
248,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
248,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
249,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
249,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
249,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
251,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
252,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
253,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
254,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
255,1,Porphyria non-acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
256,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
257,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
257,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
258,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
259,1,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
260,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
262,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
262,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
263,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
264,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
265,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
266,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
267,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
267,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
268,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
269,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
270,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
271,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
272,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
273,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
274,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
274,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
275,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
276,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
277,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
278,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
279,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
280,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
280,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
281,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
281,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
282,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
283,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
283,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
284,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
285,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
286,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
286,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
286,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
287,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
288,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
288,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
289,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
289,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
290,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
291,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
292,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
293,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
294,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
294,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
295,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
295,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
295,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
295,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
295,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
295,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
296,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
296,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
296,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
297,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
298,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
298,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
299,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
300,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
301,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
302,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
303,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
304,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
304,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
305,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
305,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
306,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
307,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
307,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
308,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
309,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
309,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
309,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
310,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
310,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
310,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
311,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
312,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
312,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
314,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,Y
315,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
315,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
315,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
316,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
316,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
317,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
317,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
317,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
317,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
318,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
318,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
318,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
318,5,Headache,Headaches NEC,Headaches,Nerv,N
318,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
319,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
319,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
321,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
321,2,Hepatic atrophy,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
321,3,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
321,4,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
321,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
322,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
323,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
324,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
325,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
326,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
327,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
327,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
327,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
328,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
329,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
330,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
331,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
331,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
332,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
332,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
332,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
333,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
334,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
335,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
336,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
337,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
338,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
339,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
339,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
340,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
340,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
341,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
341,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
342,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
342,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
344,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
344,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
345,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
345,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
345,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
346,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
346,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
347,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
348,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
349,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
349,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
349,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
349,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
349,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
349,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
349,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
349,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
349,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
350,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
350,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
350,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
350,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
351,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
351,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
352,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
352,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
352,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
352,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
353,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
354,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
355,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
355,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
355,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
356,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
357,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
358,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
359,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
359,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
360,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
361,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
362,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
362,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
362,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
362,4,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
363,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
363,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
364,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
365,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
366,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
367,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
368,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
368,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
368,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
369,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
370,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
370,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
370,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
370,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
371,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
371,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
372,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
372,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
373,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
374,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
375,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
375,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
376,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
376,2,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
377,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
378,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
378,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
378,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
379,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
380,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
380,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
381,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
381,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
382,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
382,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
382,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
383,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
384,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
384,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
384,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
384,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
385,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,Y
385,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
385,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
386,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
387,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
387,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
388,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
388,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
389,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
390,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
391,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
391,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
391,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
392,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
393,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
394,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
394,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
394,3,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
395,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
396,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
398,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
399,1,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
400,1,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
401,1,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
402,1,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,Y
403,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
404,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
405,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
406,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
407,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
408,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
409,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
410,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
410,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
410,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
411,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
412,1,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
413,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
414,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
415,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
415,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
416,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
416,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
416,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
416,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
416,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
417,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
417,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
417,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
418,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
419,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
419,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
419,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
420,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
420,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
420,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
421,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
422,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
423,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
424,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
424,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
425,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
426,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
426,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
427,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
428,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
428,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
429,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
429,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
429,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
430,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
431,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
432,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
432,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
433,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
433,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
434,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
434,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
435,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
436,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
437,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
438,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
439,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
439,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
440,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
441,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
442,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
443,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
443,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
444,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
445,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
445,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
445,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
446,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
447,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
447,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
447,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
448,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
448,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
449,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
449,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
449,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
449,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
449,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
449,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
450,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
450,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
451,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
452,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
453,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
454,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
455,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
456,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
457,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
458,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
459,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
460,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
461,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
462,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
462,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
464,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
465,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
466,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
467,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
468,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
468,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
468,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
469,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
469,2,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
470,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
471,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
472,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
473,1,Headache,Headaches NEC,Headaches,Nerv,N
473,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
474,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
475,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
476,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
477,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
477,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
478,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
479,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
480,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
480,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
480,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
480,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
480,5,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
480,6,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
480,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
481,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
482,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
483,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
484,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
485,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
486,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
486,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
487,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
488,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
488,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
488,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
489,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
489,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
489,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
489,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,1,Agnosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
490,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
490,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
490,4,Headache,Headaches NEC,Headaches,Nerv,N
490,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
490,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
490,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
490,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
490,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
490,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
491,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
492,1,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
492,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
492,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
493,1,Megakaryocytes decreased,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
494,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
495,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
496,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
496,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
496,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
497,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
498,1,Acute erythroid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
499,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
500,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
501,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
502,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
503,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
504,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
504,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
505,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
505,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
506,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
507,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
508,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
509,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
509,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
509,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
510,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
510,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
510,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
510,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
511,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
511,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
511,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
512,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
512,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
513,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
513,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
513,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
513,4,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
513,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
513,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
513,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
514,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
515,1,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
515,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
516,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
517,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
518,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
518,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
519,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
520,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
521,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
522,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
523,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
524,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
525,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
526,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
526,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
526,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
526,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
526,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
526,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
526,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
527,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
527,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
527,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
527,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
528,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
529,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
529,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
529,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
529,4,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
530,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
530,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
530,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
531,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
532,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
533,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
533,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
533,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
534,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
534,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
534,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
535,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
535,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
536,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
537,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
537,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
538,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
538,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
538,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
538,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
538,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
538,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
538,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
539,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
539,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
540,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
540,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
540,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
540,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
541,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
541,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
542,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
542,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
542,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
542,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
542,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
543,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
543,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
543,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
543,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
543,5,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
543,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
543,7,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
544,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
544,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
545,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
546,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
547,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
548,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
548,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
548,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
549,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
549,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
549,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
549,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
549,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
549,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
549,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
549,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
550,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
550,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
550,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
550,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
550,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
550,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
551,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
551,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
552,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
553,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
554,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
554,2,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
554,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
554,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
554,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
554,6,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
555,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
555,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
556,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
556,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
556,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
556,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
556,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
556,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
557,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
557,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
557,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
557,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
558,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
558,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
558,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
558,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
558,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
558,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
559,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
559,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
559,3,Lymphoma transformation,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
559,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
560,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
560,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
561,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
562,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
562,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
563,1,Carditis,Cardiac infections and inflammations NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
564,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
565,1,Oscillopsia,Visual disorders NEC,Vision disorders,Eye,N
566,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
567,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
568,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
569,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
569,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
569,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
569,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
570,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
570,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
571,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
572,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
572,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
573,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
573,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
574,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
575,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
575,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
575,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
575,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
576,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
576,2,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
576,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
576,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
577,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
577,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
578,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
579,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
580,1,Lhermitte's sign,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
580,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
581,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
581,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
581,3,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
581,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
582,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
582,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
582,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
583,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
583,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
584,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
585,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
585,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
585,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
586,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
586,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
586,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
587,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
587,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
588,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
588,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
588,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
588,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
589,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
589,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
589,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
589,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
590,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
591,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
591,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
591,3,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
592,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
593,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
593,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
593,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
593,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
593,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
593,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
594,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
594,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
595,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
595,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
595,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
596,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
597,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
597,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
597,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
598,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
598,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
598,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
599,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
600,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
601,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
601,2,Oligospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
602,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
603,1,Metastases to salivary gland,Metastases to specified sites,Metastases,Neopl,N
604,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
605,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
605,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
606,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
606,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
606,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
607,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
607,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
607,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
608,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
609,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
609,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
610,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
611,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
612,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
613,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
613,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
614,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
614,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
614,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
614,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
615,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
616,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
616,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
616,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
616,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
617,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
618,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
618,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
618,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
618,4,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
618,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
619,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
619,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
620,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
621,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
622,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
623,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
623,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
623,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
623,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
624,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
625,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
625,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
626,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
626,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
628,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
629,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
630,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
630,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
630,3,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
631,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
632,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
632,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
633,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
633,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
634,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
634,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
635,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
636,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
636,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
636,3,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
637,1,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
638,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
639,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
640,1,Granulocytes maturation arrest,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
640,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
640,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
640,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
641,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
642,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
643,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
644,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
644,2,Headache,Headaches NEC,Headaches,Nerv,N
644,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
644,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
644,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
644,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
644,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
644,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
644,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
644,10,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
645,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
645,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
645,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
646,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
646,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
646,3,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
646,4,Headache,Headaches NEC,Headaches,Nerv,N
646,5,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
646,6,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
646,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
646,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
646,9,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
646,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
646,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
647,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
648,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
648,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
648,3,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
648,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
649,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
649,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
649,3,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
649,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
650,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
650,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
650,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
650,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
650,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
650,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
651,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
651,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
651,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
651,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
651,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
651,6,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
651,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
651,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
651,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
651,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
651,11,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
651,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
652,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
652,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
652,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
653,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
653,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
654,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
654,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
654,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
655,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
655,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
655,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
655,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
655,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
655,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
655,7,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
655,8,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
655,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
655,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
655,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
655,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
655,13,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
655,14,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
656,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
656,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
657,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
657,2,Iris neovascularisation,Iris and ciliary body bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
657,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
657,4,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
657,5,Retinopathy proliferative,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
658,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
658,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
658,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
658,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
658,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
659,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
659,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
659,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
660,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
661,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
661,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
662,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
662,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
662,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
663,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
663,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
663,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
663,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
663,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
664,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
665,1,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
666,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
667,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
668,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
669,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
670,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
671,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
671,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
671,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
671,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
672,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
672,2,Headache,Headaches NEC,Headaches,Nerv,N
672,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
673,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
673,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
673,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
673,4,CD19 lymphocytes decreased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
673,5,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
673,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
673,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
673,8,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
673,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
673,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
673,11,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
673,12,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
673,13,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
673,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
673,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
673,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
674,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
674,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
674,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
674,4,Acid fast bacilli infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
674,5,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
674,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
674,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
674,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
674,9,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
674,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,11,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
674,12,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
674,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
674,14,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
674,15,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
674,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
674,17,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
674,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
674,19,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
674,20,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
674,21,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
674,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
675,1,Listeria sepsis,Listeria infections,Bacterial infectious disorders,Infec,Y
675,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
676,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
677,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
678,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
679,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
679,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
679,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
679,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
679,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
680,1,Bladder telangiectasia,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
680,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
681,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
682,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
682,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
682,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
682,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
682,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
683,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
684,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
684,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
685,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
687,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
687,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
687,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
688,1,Renal necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
689,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
690,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
690,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
690,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
690,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
691,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
692,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
693,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
694,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
694,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
695,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
695,2,CSF test abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
695,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
695,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
695,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
695,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
695,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
695,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
695,9,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
695,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
696,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
696,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
696,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
696,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
697,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
697,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
697,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
697,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
697,6,Mastectomy,Mastectomies,Breast therapeutic procedures,Surg,N
697,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
697,8,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
698,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
698,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
698,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
698,4,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
698,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
698,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
698,7,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
699,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
700,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
700,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
700,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
700,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
701,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
702,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
702,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
702,4,Moraxella infection,Moraxella infections,Bacterial infectious disorders,Infec,N
702,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
702,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
702,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
703,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
704,1,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
705,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
706,1,Deafness,Hearing losses,Hearing disorders,Ear,N
707,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
707,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
708,1,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
709,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
709,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
709,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
710,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
710,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
711,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
712,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
713,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
713,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
714,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
714,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
714,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
714,4,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
715,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
715,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
715,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
716,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
716,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
717,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
717,2,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
717,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
718,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
718,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
719,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
719,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
719,3,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
719,4,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
719,5,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
720,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
721,1,Blood luteinising hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
721,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
721,3,Testicular failure,Male gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
722,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
723,1,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
724,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
725,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
725,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
725,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
725,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
725,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
726,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
727,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
727,2,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
727,3,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
727,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
728,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
728,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
728,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
729,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
730,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
731,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
731,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
731,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
732,1,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
732,2,Bursitis infective staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
732,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
732,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
732,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
733,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
734,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
735,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
735,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
735,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
736,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
736,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
737,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
737,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
737,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
738,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
739,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
740,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
740,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
740,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
740,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
740,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
740,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
741,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
741,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
741,3,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
741,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
741,5,Headache,Headaches NEC,Headaches,Nerv,N
741,6,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
741,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
741,8,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
741,9,Liver scan abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
741,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
741,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,12,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
741,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
741,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
742,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
742,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
742,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
742,5,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
742,6,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
742,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
742,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
743,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
743,2,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
743,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
743,4,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
744,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
744,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
744,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
744,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
745,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
745,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
745,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
746,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
746,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
746,3,Cystitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
746,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
746,5,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
746,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
746,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
746,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
746,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
746,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
746,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
747,1,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
748,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
749,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
749,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
750,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
750,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
750,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
750,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
750,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
751,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
751,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
752,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
753,1,Anti-thyroid antibody positive,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
754,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
754,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
754,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
756,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
756,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,1,Cytomegalovirus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
758,1,Anti-thyroid antibody positive,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
758,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
759,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
759,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
759,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
759,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
760,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
760,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
761,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
762,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
762,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
762,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
762,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
762,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
763,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
764,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
764,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
764,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
765,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
765,2,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
765,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
765,4,Burkitt's lymphoma stage III,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
765,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
765,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
765,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
765,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
765,10,Vascular graft complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
766,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
766,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
766,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
767,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
767,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
767,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
767,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
768,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
768,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
768,3,Citrobacter sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
768,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
768,5,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
768,6,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
768,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
768,8,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
768,9,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
769,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
770,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
771,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
772,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
772,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
772,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
772,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
772,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
773,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
773,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
773,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
773,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
773,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
773,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
773,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
773,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
773,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
773,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
773,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
773,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
773,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
773,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
773,15,Tic,Tic disorders,Changes in physical activity,Psych,N
774,1,Bladder fibrosis,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
774,2,Catheterisation venous,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
774,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
774,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
774,5,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
774,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
774,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
775,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
776,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
778,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
778,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
778,4,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
779,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
780,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
781,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
782,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
782,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
782,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
782,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
783,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
783,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
784,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
785,1,Renal necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
786,1,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
786,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
787,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
787,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
787,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
787,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
788,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
788,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
788,3,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
789,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
789,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
789,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
789,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
790,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
790,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
790,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
790,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
790,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
790,6,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
790,7,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
790,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
790,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
790,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
790,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
791,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
791,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
792,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
793,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
794,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
794,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
795,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
796,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
797,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
798,1,Pelvic kidney,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
798,2,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
799,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
800,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
800,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
801,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
801,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
801,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
801,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
801,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
801,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
801,7,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
802,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
802,2,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
802,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
803,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
803,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
804,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
805,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
805,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
805,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
805,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
806,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
806,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
806,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
806,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
807,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
807,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
807,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
808,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
808,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
808,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
809,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
809,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
809,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
810,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
810,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
810,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
810,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
811,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
811,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
811,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
811,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
811,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
811,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
811,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
812,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
813,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
814,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
814,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
814,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
815,1,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
815,2,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
815,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
815,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
815,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
815,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
815,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
816,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
817,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
817,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
817,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
817,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
818,1,Megakaryocytes abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
818,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
819,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
820,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
821,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
821,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
821,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
822,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
822,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
822,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
823,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
823,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
824,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
824,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
825,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
825,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
825,3,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
825,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
825,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
826,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
827,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
827,2,Headache,Headaches NEC,Headaches,Nerv,N
827,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
828,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
829,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
829,2,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
829,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
829,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
830,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
830,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
831,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
831,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
831,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
831,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
831,5,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
831,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
831,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
831,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
831,9,Eschar,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
831,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
831,11,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
831,12,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
831,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
831,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
831,15,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
831,16,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
832,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
832,2,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
832,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
832,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
832,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
832,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
833,1,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
834,1,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
835,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
835,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
836,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
836,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
836,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
836,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
836,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
837,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
838,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
838,2,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
838,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
838,4,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
838,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
838,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
839,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
840,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
840,2,Headache,Headaches NEC,Headaches,Nerv,N
840,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
840,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
840,5,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
840,6,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
840,7,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
841,1,Follicular mucinosis,Alopecias,Skin appendage conditions,Skin,N
841,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
842,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
843,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
843,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
843,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
844,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
844,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
845,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
845,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
846,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
847,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
848,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
849,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
850,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
850,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
850,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
850,4,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
850,5,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
850,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
850,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
851,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
852,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
852,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
853,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
854,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
855,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
855,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
855,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
855,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
855,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
856,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
857,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
857,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
858,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
859,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
859,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
860,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
860,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
860,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
860,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
860,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
861,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
862,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
862,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
863,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
863,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
863,3,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
863,4,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
863,5,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
863,6,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
863,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
863,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
863,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
863,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
863,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
863,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
863,13,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
863,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
864,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
865,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
866,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
867,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
868,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
868,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
869,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
870,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
870,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
870,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
870,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
870,5,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
871,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
871,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
871,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
872,1,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
872,2,Pneumonia respiratory syncytial viral,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
872,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
872,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
873,1,Enterobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
873,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
874,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
875,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
875,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
876,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
877,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
878,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
878,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
879,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
880,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
881,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
881,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
881,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
882,1,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
883,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
883,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
884,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
884,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
884,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
884,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
885,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
886,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
886,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
887,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
888,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
889,1,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
890,1,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
891,1,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
892,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
892,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
892,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
892,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
892,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
892,6,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
892,7,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
892,8,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
892,9,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
892,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
892,11,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
892,12,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
892,13,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
892,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
893,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
893,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
893,3,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
894,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
894,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
894,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
894,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
894,5,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
894,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
894,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
894,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
894,9,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
894,10,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
894,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
894,12,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
894,13,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
894,14,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
894,15,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
894,16,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
894,17,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
894,18,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
895,1,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
895,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
895,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
895,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
895,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
896,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
896,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
896,3,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
897,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
897,2,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
897,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
897,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
897,5,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
897,6,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
897,7,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
897,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
897,9,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
897,10,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
898,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
898,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
898,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
898,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
899,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
899,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
899,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
899,4,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
899,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
899,6,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
899,7,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
899,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
900,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
900,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
901,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
901,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
901,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
901,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
901,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
901,6,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
901,7,Laryngeal stenosis,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
901,8,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
901,9,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
901,10,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
901,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
902,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
902,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
903,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
903,2,Bronchostenosis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
903,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
903,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
903,5,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
903,6,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
903,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
904,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
904,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
904,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
904,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
904,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
905,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
905,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
906,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
907,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
908,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
909,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
910,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
911,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
911,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
911,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
911,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
911,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
911,6,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
911,7,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
911,8,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
911,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
911,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
911,11,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
911,12,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
911,13,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
911,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
911,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
912,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
912,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
912,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
912,4,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
912,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
912,6,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
912,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
912,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
912,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
912,10,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
913,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
913,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
913,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
913,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
913,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
913,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
913,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
913,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
913,9,Refractoriness to platelet transfusion,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
913,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
913,11,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
913,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
914,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
915,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
916,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
917,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
917,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
917,3,Headache,Headaches NEC,Headaches,Nerv,N
917,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
917,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
917,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
917,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
918,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
918,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
918,3,Diffuse large B-cell lymphoma stage II,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
918,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
918,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
918,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
918,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
918,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
918,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
918,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
918,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
918,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
919,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
919,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
919,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
919,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
919,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
919,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
919,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
919,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
920,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
920,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
920,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
920,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
920,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
921,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
921,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
921,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
922,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
922,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
923,1,Fallot's tetralogy,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,N
923,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
923,3,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
924,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
924,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
924,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
924,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
924,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
924,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
924,7,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
924,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
924,9,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
924,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
925,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
925,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
926,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
926,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
926,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
926,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
927,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
927,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
928,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
928,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
929,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
929,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
929,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
930,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
930,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
930,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
930,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
930,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
930,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
931,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
932,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
932,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
932,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
933,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
934,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
935,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
936,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
936,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
937,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
937,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
938,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
938,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
939,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
939,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
940,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
940,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
941,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
941,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
942,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
942,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
943,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
943,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
944,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
944,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
945,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
945,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
946,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
947,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
948,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
949,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
950,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
951,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
951,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
951,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
952,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
952,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
952,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
953,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
953,2,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
954,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
954,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
954,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
954,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
954,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
954,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
954,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
954,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
954,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
954,10,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
954,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
954,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
954,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
954,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
954,15,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
954,16,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
955,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
955,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
956,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
956,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
956,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
956,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
956,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
956,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
956,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
956,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
956,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
956,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
957,1,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
958,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
959,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
960,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
961,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
962,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
963,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
964,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
965,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,Y
966,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
967,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
968,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
969,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,Y
970,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
971,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
972,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,Y
973,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
973,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
974,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
974,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
974,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
974,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
975,1,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
975,2,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
976,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
976,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
976,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
976,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
977,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
978,1,Cytomegalovirus oesophagitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
978,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
978,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
978,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
978,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
978,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
979,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
979,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
979,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
979,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
979,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
979,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
979,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
979,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
979,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
979,10,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
979,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
980,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
980,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
980,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
980,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
981,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
981,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
981,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
982,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
982,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
983,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
983,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
983,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
983,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
984,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
984,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
985,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
985,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
985,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
986,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
986,2,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
986,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
987,1,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
988,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
989,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
989,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
990,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
991,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
991,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
991,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
991,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
991,5,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
991,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
991,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
991,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
991,9,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
991,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
991,11,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
991,12,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
991,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
991,14,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
992,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
993,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
994,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
994,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
994,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
994,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
994,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
994,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
994,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
994,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
994,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
995,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
995,2,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
995,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
995,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
996,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
996,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
997,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
998,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
999,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
999,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
999,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
999,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1000,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1000,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1000,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1000,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1000,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1000,6,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1000,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1000,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1000,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1000,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1000,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1000,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1000,13,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1001,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1002,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1003,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1004,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1005,1,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1005,2,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,Y
1005,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1006,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1006,2,Headache,Headaches NEC,Headaches,Nerv,N
1006,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1006,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1006,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1006,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1007,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1007,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1007,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1007,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1007,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1007,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1007,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1007,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1008,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1008,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1008,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1009,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1009,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1009,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1010,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1010,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1010,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1011,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1011,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1011,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1012,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1012,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1013,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1013,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1013,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1014,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1014,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1015,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1015,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1015,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1015,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1015,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1015,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1016,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1016,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1017,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1017,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1017,3,Implant site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1017,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1018,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1018,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1018,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1018,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1019,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1019,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1019,3,Rickets,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1020,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1021,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1022,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1023,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1024,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1025,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1026,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1027,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1028,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1029,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1029,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1030,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1030,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1030,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1030,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1031,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1031,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1031,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1031,4,Headache,Headaches NEC,Headaches,Nerv,N
1031,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1031,6,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1031,7,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1031,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1031,9,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1032,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1033,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1034,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1035,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1036,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1036,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1037,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1037,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1037,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1038,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1039,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1040,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1041,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1042,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1043,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1044,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1045,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1046,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1047,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1048,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1049,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1050,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1051,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1052,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1053,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1054,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1055,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1056,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1057,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1058,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1059,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1060,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1061,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1062,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1063,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1064,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1065,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1065,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1065,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1065,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1066,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1066,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1067,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1067,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1067,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1068,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1068,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1068,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1068,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1069,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1070,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1071,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1071,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1071,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1071,4,Laryngitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1071,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1071,6,Pilonidal disease,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1071,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1072,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1073,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1073,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1073,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1074,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1075,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1075,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1075,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1075,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1075,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1075,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1075,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1075,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1075,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1075,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1075,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1075,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1076,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1076,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1077,1,Candida test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
1077,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1077,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1077,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1077,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1077,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1077,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1077,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1077,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1078,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1079,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1079,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1079,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1079,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1079,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1079,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1079,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1079,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1079,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1079,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1079,11,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1079,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1080,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1080,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1080,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1081,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1081,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1082,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1082,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1083,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1083,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1083,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1084,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1084,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1084,3,Headache,Headaches NEC,Headaches,Nerv,N
1084,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1084,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1084,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1085,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1085,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1086,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1086,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1087,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1087,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1088,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1088,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1088,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1088,4,Myelodysplastic syndrome with excess blasts,Myelodysplastic syndromes,Leukaemias,Neopl,N
1088,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1088,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1089,1,Breast cancer male,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1090,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1091,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1091,2,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1091,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1091,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1091,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1091,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1092,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1093,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1094,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1094,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1094,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1094,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1094,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1095,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
1096,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1097,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1098,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1098,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1099,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1099,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1100,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1100,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1100,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1100,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1100,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1100,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1100,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1100,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1100,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1101,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1102,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1103,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1104,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1104,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1104,3,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1105,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1106,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1106,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1107,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1108,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1108,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1108,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1109,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1109,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1109,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1109,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1109,5,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
1109,6,Sarcoma metastatic,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
1109,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1109,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1110,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1111,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1111,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1111,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1112,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1113,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1113,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1113,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1113,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1113,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1113,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1113,7,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1114,1,Carotid artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1114,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1114,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1114,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1114,5,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1114,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1114,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1114,8,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1114,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1114,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1114,11,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1115,1,Testicular neoplasm,Reproductive neoplasms male unspecified malignancy,Reproductive neoplasms male malignant and unspecified,Neopl,N
1116,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1116,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1116,3,Headache,Headaches NEC,Headaches,Nerv,N
1116,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1116,5,Infusion site nerve damage,Infusion site reactions,Administration site reactions,Genrl,N
1116,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1116,7,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1117,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1117,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1117,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1118,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1119,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1120,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1121,1,Tooth resorption,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1122,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1122,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1122,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1122,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1123,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1123,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1123,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1123,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1124,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1124,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1124,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1124,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1124,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1124,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1124,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1125,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1125,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1126,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1126,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1127,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1127,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1127,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1127,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1127,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1127,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1127,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1127,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1127,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1127,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1127,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1127,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1127,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1127,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1127,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1128,1,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1128,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1129,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
1129,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1129,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1130,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1131,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
1131,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1131,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1132,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1132,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1132,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1132,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1132,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1132,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1133,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1133,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1134,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1135,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1135,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1136,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1137,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1137,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1138,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1139,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1140,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1140,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1140,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1141,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1141,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1141,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1141,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1141,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1142,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1142,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1142,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1142,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1142,5,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1142,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1142,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1142,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1142,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1142,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1143,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1143,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1143,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1144,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1145,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1145,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1146,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1146,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1146,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1147,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1147,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
1148,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1148,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1148,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1148,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1149,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1149,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1150,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1150,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1150,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1150,4,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1150,5,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1151,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1151,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1151,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1152,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1152,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1153,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1154,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1155,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1156,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1156,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1156,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1156,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1157,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1158,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1159,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1159,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1160,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1160,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1160,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1160,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1160,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1161,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1162,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1162,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1163,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1163,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1164,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1164,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1165,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1166,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1167,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1168,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1169,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1169,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1169,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1169,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1169,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1169,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1169,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1169,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1169,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1169,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1170,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1170,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1170,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1170,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1170,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1170,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1170,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1170,8,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1170,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1171,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1171,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1171,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1171,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1171,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1171,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1171,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1171,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1171,9,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1171,10,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1172,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1172,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1172,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1172,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1172,5,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
1172,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1172,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1172,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1172,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1172,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1172,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1173,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1173,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1173,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1173,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1173,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1173,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1173,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1173,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1173,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1173,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1173,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1174,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1174,2,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1174,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1174,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1174,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1174,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1174,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1174,8,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1174,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1174,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1174,11,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1174,12,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1175,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1175,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1175,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1175,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1175,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1175,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1175,7,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1175,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1175,9,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1175,10,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1175,11,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1175,12,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1175,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1175,14,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1175,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1175,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1175,17,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1175,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1176,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1176,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1176,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
1176,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1176,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1176,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1177,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1177,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1177,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1178,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1179,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1180,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1181,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1182,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1182,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1182,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1183,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1184,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1185,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1186,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1187,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1188,1,Metastases to skin,Metastases to specified sites,Metastases,Neopl,Y
1189,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1189,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1190,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1191,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1191,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1192,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1193,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1194,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1195,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1195,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1195,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1195,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1195,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1196,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1196,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1196,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1196,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1196,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1196,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1196,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1197,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1197,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1197,3,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1197,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1197,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1197,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1197,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1197,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1197,9,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1197,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1197,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1198,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
1198,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1199,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1200,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
1200,2,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1200,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1201,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1201,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1201,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1202,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1202,2,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1202,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1203,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1203,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1204,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1204,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1204,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1204,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1204,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1204,6,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1204,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1204,8,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1204,9,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
1204,10,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1204,11,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1204,12,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1204,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1204,14,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1204,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1205,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1205,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1206,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1206,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1207,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1207,2,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
1207,3,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1207,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1207,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1208,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1208,2,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,Y
1209,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1209,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1210,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1210,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1210,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1210,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1210,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1210,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1210,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1210,8,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1210,9,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1210,10,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1210,11,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1210,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1210,13,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1210,14,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1210,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1210,16,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1210,17,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1210,18,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1211,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1211,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1211,3,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1212,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1212,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1212,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1212,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1212,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1212,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1212,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1212,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1212,9,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1212,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1213,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1214,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1214,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1215,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1216,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1217,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1218,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1218,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1219,1,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
1219,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1219,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1220,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1220,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1220,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1221,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1221,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1221,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1221,4,Headache,Headaches NEC,Headaches,Nerv,N
1221,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1222,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1222,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1222,3,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1222,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1222,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1223,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1223,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1223,3,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1223,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1224,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1224,2,Headache,Headaches NEC,Headaches,Nerv,N
1224,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1224,4,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1225,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1225,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1225,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1226,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1226,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1227,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1227,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1227,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1227,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1228,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1228,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1228,3,Headache,Headaches NEC,Headaches,Nerv,N
1228,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1228,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1228,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1228,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1229,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1229,2,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
1229,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1229,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1229,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1230,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1230,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1230,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1230,4,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1231,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1231,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1231,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1231,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1231,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1231,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1231,7,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1232,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1232,2,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1232,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1232,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1233,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1233,2,Headache,Headaches NEC,Headaches,Nerv,N
1233,3,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1233,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1233,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1234,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1234,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1234,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1234,4,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1234,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1235,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1235,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1235,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1235,4,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1235,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1235,6,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1236,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1236,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1236,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1237,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1237,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1237,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1237,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1238,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1238,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1238,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1239,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1239,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1239,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1240,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1240,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1240,3,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1240,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1240,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1240,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1241,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1241,2,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
1241,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1241,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1241,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1241,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1242,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1242,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1242,3,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1242,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1242,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1243,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1244,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1244,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1244,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1244,4,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1244,5,Headache,Headaches NEC,Headaches,Nerv,N
1244,6,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1244,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1244,8,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1245,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1245,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1245,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1246,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1246,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1247,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1247,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1247,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1247,4,Headache,Headaches NEC,Headaches,Nerv,N
1247,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1247,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1247,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1247,8,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1248,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1248,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1248,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1248,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1248,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1248,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1248,7,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1248,8,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1249,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1249,2,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1249,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1249,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1249,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1250,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1250,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1250,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1250,4,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1250,5,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1250,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1251,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1251,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1251,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1251,4,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1251,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1251,6,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1251,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1251,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1251,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1252,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1252,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1253,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
1253,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1254,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1254,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1255,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1255,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1255,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1256,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1256,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1256,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1257,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1257,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1257,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1258,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1258,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1258,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1259,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1259,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1259,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1259,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1260,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1261,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1261,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1262,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1262,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1262,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1262,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1262,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1263,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1264,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1265,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1265,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1266,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1266,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1266,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1266,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
1267,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1267,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1267,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1268,1,Disseminated Bacillus Calmette-Guerin infection,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1268,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1268,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1268,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1269,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1269,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1269,3,Endoscopy upper gastrointestinal tract abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
1269,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1269,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1269,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1269,7,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1269,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1269,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1269,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1269,11,Oesophagitis haemorrhagic,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1269,12,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1269,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1269,14,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1269,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1270,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1270,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1271,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1271,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1271,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1271,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1271,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1272,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1272,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1273,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
1273,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1273,3,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1273,4,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1273,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1273,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1273,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1273,8,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
1273,9,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1273,10,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1274,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1274,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1274,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1274,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1275,1,Cytomegalovirus gastroenteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1275,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1275,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1275,4,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1275,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1275,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1275,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1275,8,Shock haemorrhagic,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1275,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1275,10,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1276,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1276,2,Faecal vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1276,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1277,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1277,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1277,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1278,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1278,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1278,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1279,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1279,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1279,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1279,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1280,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1280,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1280,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1280,4,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1280,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1281,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1281,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1281,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1281,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1282,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
1282,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,3,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1282,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1283,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1283,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1284,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1284,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1285,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1286,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1287,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1287,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1287,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1287,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1288,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1288,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1288,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1289,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1290,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1291,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1291,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1291,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1292,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1292,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1292,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1292,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1292,5,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1292,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1293,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1294,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1294,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1294,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1294,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1295,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1295,2,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
1296,1,Aeromonas infection,Aeromonas infections,Bacterial infectious disorders,Infec,N
1296,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1297,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1297,2,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
1298,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1299,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1300,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1301,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1301,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1301,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
1301,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1301,5,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1302,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1302,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1303,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1303,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1304,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1304,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1305,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1305,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1305,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1305,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1305,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1306,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1307,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1307,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1308,1,Carbohydrate antigen 15-3 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1308,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1308,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1308,4,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1309,1,Headache,Headaches NEC,Headaches,Nerv,N
1309,2,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1309,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1309,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1310,1,BK polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1310,2,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1311,1,BK polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1311,2,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1312,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1312,2,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1313,1,BK polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1313,2,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1314,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1314,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1315,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1316,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1317,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1317,2,Headache,Headaches NEC,Headaches,Nerv,N
1317,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1317,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1318,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1318,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1319,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1319,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1319,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1320,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1321,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1322,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1322,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1322,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1323,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1323,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1323,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1324,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1324,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1324,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1324,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1324,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1324,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1325,1,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
1326,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
1326,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1326,3,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
1327,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1327,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1327,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1327,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1327,5,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1327,6,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1327,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1327,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1327,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1327,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1327,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1327,12,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1327,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1328,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1328,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1329,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1330,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1330,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1331,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1331,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1331,3,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1331,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1331,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1332,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
1332,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1333,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1333,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1334,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1334,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1334,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1335,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1335,2,Headache,Headaches NEC,Headaches,Nerv,N
1335,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1335,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1335,5,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1335,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1336,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1336,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1337,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1338,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1339,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1340,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1341,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1342,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1343,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1344,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1345,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1346,1,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1346,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1347,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1348,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1349,1,Brachiocephalic vein thrombosis,Site specific embolism and thrombosis NEC,Embolism and thrombosis,Vasc,N
1349,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1350,1,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1350,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1351,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1352,1,Brachiocephalic vein thrombosis,Site specific embolism and thrombosis NEC,Embolism and thrombosis,Vasc,N
1352,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1353,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1354,1,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1354,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1355,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1356,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1357,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1358,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1359,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1359,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1359,3,Oesophagitis haemorrhagic,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
1360,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1361,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1361,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1361,3,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1361,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1361,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1361,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1361,7,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1361,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1361,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1361,10,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1361,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1361,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1361,13,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1361,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1362,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1363,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1364,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1365,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1366,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1367,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1368,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1369,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1370,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1371,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1372,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1373,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1373,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1373,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1373,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1374,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1374,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1375,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1376,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1377,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1378,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1379,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1380,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1380,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1380,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1380,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1380,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1380,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1380,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1381,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1381,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1381,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1381,4,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1381,5,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1381,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1381,7,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1381,8,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1381,9,Catheter site erythema,Implant and catheter site reactions,Administration site reactions,Genrl,N
1381,10,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
1381,11,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
1381,12,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1381,13,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1381,14,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1381,15,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1381,16,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,17,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1381,18,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1381,19,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1381,20,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1381,21,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1381,22,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1381,23,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1381,24,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1381,25,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1381,26,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1381,27,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1381,28,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1381,29,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1381,30,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1381,31,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1381,32,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1381,33,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1381,34,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1381,35,Sinus headache,Headaches NEC,Headaches,Nerv,N
1381,36,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,37,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1381,38,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
1381,39,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1382,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1382,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1383,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1384,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1384,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1385,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1386,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1386,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1387,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1387,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1388,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1388,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1389,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1390,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1390,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1390,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1390,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1391,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1391,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1392,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1392,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1392,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1392,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1392,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1392,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1393,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1394,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1396,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1396,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1397,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1397,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1397,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1397,4,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1397,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1397,6,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1397,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1397,8,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1397,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1397,10,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
1397,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1397,12,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1397,13,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1397,14,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1397,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1397,16,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1397,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1397,18,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1397,19,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1397,20,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1397,21,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1398,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1398,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1398,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1399,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1400,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
1400,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1401,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1402,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1403,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1403,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1404,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
1405,1,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1406,1,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1407,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1407,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1407,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1407,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1407,5,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1407,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1407,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1407,8,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1407,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
1407,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1407,11,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1407,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1407,13,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1407,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1407,15,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1407,16,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1408,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1408,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1408,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1408,4,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1408,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1408,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1408,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1408,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1408,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1408,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1408,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1408,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1409,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1409,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1410,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1410,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1411,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1412,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1412,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1413,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1414,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1414,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1414,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1415,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1415,2,Disseminated varicella zoster vaccine virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
1415,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1416,1,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1416,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1416,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1416,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1417,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1417,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1417,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1417,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1417,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1417,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1417,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1417,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1417,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1417,10,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1417,11,Headache,Headaches NEC,Headaches,Nerv,N
1417,12,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1417,13,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1417,14,Intercepted product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1417,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1417,16,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1417,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1417,18,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1417,19,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1417,20,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1417,21,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1417,22,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1417,23,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1417,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1418,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1418,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1418,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1418,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1418,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1418,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1418,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1418,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1419,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1419,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1420,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1420,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1420,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1421,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1421,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1422,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1422,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1423,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1423,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1423,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1423,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1423,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1423,6,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1423,7,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1423,8,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
1423,9,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
1423,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1423,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1423,12,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1423,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1423,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1423,15,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1423,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1423,17,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1423,18,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1424,1,"Follicle centre lymphoma, follicular grade I, II, III recurrent",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1424,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1425,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1425,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1425,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1425,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1425,5,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1425,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1425,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1426,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1426,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1426,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1427,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1427,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1427,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1427,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1427,5,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
1428,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1429,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1430,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1431,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1431,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1431,3,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1431,4,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1431,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1431,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1432,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1432,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1432,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1432,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1433,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1433,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1434,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1435,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1436,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1436,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1436,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1437,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1437,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1437,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1437,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1437,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1437,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1438,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1438,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1438,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1438,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1438,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1438,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1439,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1439,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1439,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1439,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1439,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1440,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1440,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1440,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1440,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
1441,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1441,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1441,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1441,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1441,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1442,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1442,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1442,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1443,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1443,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1443,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1443,4,Lymphodepletion,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1443,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1443,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1443,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1443,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1444,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1445,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1446,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1447,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1447,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1447,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1447,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1448,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1448,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1448,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1448,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1448,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1449,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1449,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1449,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1449,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1449,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1449,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1449,7,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
1449,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1449,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1449,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1450,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1451,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1451,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1451,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1452,1,Inflammatory myofibroblastic tumour,Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas),Soft tissue neoplasms malignant and unspecified,Neopl,N
1453,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1454,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1455,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1456,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1457,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1458,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1458,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1458,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1459,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1459,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1460,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1460,2,Neurofibromatosis,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
1461,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1461,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1462,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1463,1,Ependymoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1463,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1463,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1464,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1464,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1465,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1465,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1465,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1465,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1465,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1465,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1465,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1465,8,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1465,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1465,10,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1465,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1465,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1465,13,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1466,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1467,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1467,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1467,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1467,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1467,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1467,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1467,7,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1467,8,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1467,9,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1467,10,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1467,11,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1467,12,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1467,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1467,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1467,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1467,16,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1467,17,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1467,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1467,19,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1467,20,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1468,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1468,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1468,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1469,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1470,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
1470,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1470,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1471,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1471,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1472,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1472,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
1473,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1474,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1474,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1474,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1474,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1474,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1475,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1476,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1476,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1476,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1476,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1477,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1477,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1478,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1479,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1479,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1479,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1480,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1480,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
1480,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1480,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1481,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1482,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1483,1,Infusion site discomfort,Infusion site reactions,Administration site reactions,Genrl,N
1483,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1483,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1484,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
1484,2,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1484,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1484,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1485,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1486,1,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
1487,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1487,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1487,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1487,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1487,5,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
1487,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1487,7,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1487,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1487,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1487,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1487,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1487,12,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1488,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1488,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1489,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1489,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1489,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1490,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1490,2,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
1491,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1491,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1491,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1492,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
1492,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1493,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1494,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1495,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1496,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1496,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1496,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1497,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1498,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1498,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1499,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1499,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
1499,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
1499,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1499,5,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1499,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1499,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1499,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1500,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1501,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1501,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1501,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1501,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1501,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1501,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1502,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1502,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1502,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1502,4,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1503,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1503,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1504,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1504,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1505,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1505,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1505,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1506,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1506,2,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
1506,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1507,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1507,2,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
1507,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1507,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1507,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1507,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1508,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1509,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1509,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1509,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1509,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1509,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1510,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1510,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1510,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1510,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1511,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1512,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1512,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1513,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1514,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1514,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1515,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1516,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1516,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1516,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1516,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1517,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1517,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1517,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1517,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1518,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1518,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1519,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1520,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1521,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1522,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1522,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1523,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1523,2,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1524,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1524,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1524,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1524,4,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1524,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1524,6,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1524,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1524,8,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1524,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1524,10,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1525,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1526,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1526,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1526,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1527,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1528,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1529,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1530,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1530,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1531,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1531,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1531,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1531,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1531,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1531,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1531,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1531,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1531,9,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1531,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1532,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1532,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1532,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1532,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1532,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1532,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1532,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1532,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1532,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1533,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1533,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1533,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1533,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1533,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1533,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1533,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1533,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1533,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1534,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1535,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1535,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1536,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
1536,2,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1536,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
1536,4,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1536,5,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1536,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1537,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1537,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1537,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1537,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1537,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1538,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1538,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1539,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1540,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1540,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1541,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1541,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1542,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1542,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1542,3,Haemofiltration,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1542,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1542,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1542,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1542,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1542,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1542,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1542,10,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
1543,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1543,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,Y
1543,3,Headache,Headaches NEC,Headaches,Nerv,N
1543,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1543,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1544,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1544,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1545,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1545,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1545,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1546,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1547,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1547,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1548,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1549,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1550,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1550,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1551,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1552,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1553,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1553,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1554,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1554,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1554,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1554,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1554,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1554,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1554,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1554,8,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1554,9,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
1554,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1554,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1554,12,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1555,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1555,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1556,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1556,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1556,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1556,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1557,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1558,1,Citrate toxicity,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1558,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1558,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1561,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1562,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1562,2,Salivary gland pain,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
1563,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1563,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1564,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1564,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1565,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1565,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1566,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1566,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1567,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1567,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1568,1,Choroidal effusion,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1568,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1569,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1569,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1569,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1569,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1570,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1570,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1570,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1570,4,Scar pain,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1570,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1570,6,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1571,1,Antineutrophil cytoplasmic antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1571,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1571,3,Lacrimal haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
1572,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1572,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1572,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1573,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1573,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1573,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,Y
1573,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1574,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1574,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1575,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1576,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1576,2,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1577,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1577,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1577,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1578,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1578,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1578,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1578,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1579,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1579,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1579,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1579,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1579,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1579,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1579,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1579,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1580,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1580,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1580,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1580,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1581,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1581,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1581,3,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1581,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1581,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1582,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1582,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1582,3,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
1582,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1582,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1582,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1582,7,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1582,8,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1583,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1583,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1584,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1584,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1584,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1584,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1584,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1584,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
1584,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1585,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1585,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1585,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1585,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1585,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1585,6,Headache,Headaches NEC,Headaches,Nerv,N
1585,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1585,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1585,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1585,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1586,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1587,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1587,2,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1588,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1588,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1588,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1588,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1589,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1589,2,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1589,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1589,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1589,5,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1589,6,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1589,7,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1589,8,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1590,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1590,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1591,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1591,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1591,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1591,4,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,Y
1592,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1592,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1592,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1592,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1592,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1592,6,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1592,7,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
1592,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1593,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1593,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1593,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1594,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1594,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
1594,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1594,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1594,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1594,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1594,7,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
1595,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1595,2,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1595,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1595,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1596,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1596,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1597,1,Glioneuronal tumour,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1597,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1598,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1598,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1599,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1599,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1600,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1601,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1601,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1601,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1602,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
1602,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1602,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1602,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1603,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1604,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1605,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1605,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1606,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1607,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1608,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1608,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1608,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1608,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1608,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1608,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1609,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1610,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1610,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1610,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1610,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1610,5,Postictal state,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1610,6,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
1611,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1612,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1612,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1612,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1613,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1613,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1613,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1613,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1614,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1614,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1615,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1615,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1615,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1616,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1616,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1617,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1617,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1617,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1617,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1617,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1618,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1618,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1618,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1618,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1618,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1619,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1620,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1621,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1621,2,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1622,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1622,2,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1623,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1623,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1624,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1625,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1626,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1626,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1626,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1627,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1627,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
1627,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1627,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1627,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1627,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1628,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1629,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1630,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1630,2,Optic glioma,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
1631,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1631,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1631,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1631,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1631,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1632,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1632,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1632,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1632,4,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1632,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1632,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1632,7,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1632,8,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1632,9,Headache,Headaches NEC,Headaches,Nerv,N
1632,10,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1632,11,Lupus myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1632,12,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1632,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1632,14,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1632,15,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1632,16,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1632,17,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1632,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1633,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1633,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1633,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1633,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1633,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1633,6,Lupus myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1633,7,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1633,8,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1633,9,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1633,10,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1633,11,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1634,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1635,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1635,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1636,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1636,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1637,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1637,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1637,3,Mucosal haemorrhage,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1637,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1637,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1637,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1638,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1638,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1639,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1640,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1640,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1640,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1641,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1641,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1641,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1641,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1641,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1642,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1643,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1644,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1644,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1645,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1645,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1645,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1645,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1645,5,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1645,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1645,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1645,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1645,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1645,10,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1645,11,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1646,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1647,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1647,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1647,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1647,4,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1647,5,Meningoencephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1648,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1648,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1648,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1648,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1648,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1649,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1650,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1650,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1651,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1651,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1651,3,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1652,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1652,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1653,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1653,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1654,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1654,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1654,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1654,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1654,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1654,6,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1654,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1654,8,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1655,1,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1656,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1656,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1656,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1656,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1656,5,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1657,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
1657,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1658,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1659,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1659,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1660,1,BK polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1661,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1661,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1662,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1662,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1662,3,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1663,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1663,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1663,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1663,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1663,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1663,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1663,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1663,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1664,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1664,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1664,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1664,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1664,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1664,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1664,7,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1664,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1665,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1665,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1666,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1666,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1666,3,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1666,4,Funnel chest acquired,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1666,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1666,6,Pleural fibrosis,Pleural conditions NEC,Pleural disorders,Resp,N
1666,7,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
1666,8,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1666,9,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1666,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1667,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1667,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1667,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1668,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1668,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1669,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1670,1,Ovarian cancer stage III,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1670,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1671,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1672,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1673,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1673,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1673,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1673,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1673,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1673,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1674,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1674,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1674,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1674,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1674,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1674,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1674,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1674,8,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
1674,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1674,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1675,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1676,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1677,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1677,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1677,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1678,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1679,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1680,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1680,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1681,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1681,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1681,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1681,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1681,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1681,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1681,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1682,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1683,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1683,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1684,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1684,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1684,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1684,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1684,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1685,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1686,1,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1687,1,B-cell lymphoma stage IV,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1687,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1687,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1687,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1688,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1688,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1688,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1688,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1688,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1688,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1689,1,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
1689,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1690,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1690,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1690,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1690,4,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1690,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1690,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1690,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1690,8,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1690,9,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1690,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1690,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1690,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1691,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1692,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1693,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1693,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1693,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1693,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1693,5,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1694,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1694,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1694,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1695,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1696,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1697,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1697,2,Headache,Headaches NEC,Headaches,Nerv,N
1697,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1697,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1698,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1698,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1699,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
1699,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1699,3,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1699,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1700,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1701,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1702,1,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1702,2,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1702,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1702,4,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
1702,5,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1702,6,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1702,7,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1702,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1703,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1703,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1703,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1703,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1703,5,Septic vasculitis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1703,6,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1703,7,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1704,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1704,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1704,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1704,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1704,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1704,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1704,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1705,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1705,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1705,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1705,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1706,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1706,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1707,1,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1707,2,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1707,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,4,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
1707,5,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1707,6,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1708,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1708,2,Catheter site bruise,Implant and catheter site reactions,Administration site reactions,Genrl,N
1708,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1708,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1708,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1708,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1708,7,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1708,8,Headache,Headaches NEC,Headaches,Nerv,N
1708,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1708,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
1708,11,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1708,12,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1708,13,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1708,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1708,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1709,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1710,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1710,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1710,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1710,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1710,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1711,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1712,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1712,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1712,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1712,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1712,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1712,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1712,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1713,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1713,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1714,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1714,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1715,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1715,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1715,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1715,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1716,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1717,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1718,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1718,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1718,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1718,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1718,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1718,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1718,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1718,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1718,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1718,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1718,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1718,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1718,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1718,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1718,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
1718,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1719,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1719,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1719,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1719,4,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1720,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1721,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1721,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1721,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1721,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1721,5,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1721,6,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1721,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1721,8,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1721,9,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1721,10,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1721,11,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1721,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1721,13,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1722,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1722,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1723,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1723,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1724,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1725,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1725,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1725,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1725,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1726,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1726,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1726,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1726,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1726,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1727,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1727,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1727,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1727,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1728,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
1728,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1728,3,Blast cells present,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1728,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1728,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1728,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1728,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1728,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1728,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1728,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1728,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1729,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1730,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1731,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1732,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1732,2,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1733,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1733,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1734,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1734,2,Appendiceal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1734,3,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1735,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1735,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1736,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1737,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1737,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1737,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1738,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1738,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1738,3,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1738,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1738,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1739,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1739,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1739,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1739,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1739,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1739,6,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1739,7,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1740,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1740,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,Y
1740,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1741,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1742,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1742,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1743,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1743,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
1743,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1744,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1744,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1745,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1745,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1746,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1746,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1746,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1747,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
1748,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1748,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1748,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1748,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1748,5,Fungal test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
1748,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1748,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1748,8,Respirovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1749,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1749,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1749,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1750,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1751,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1751,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1751,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1751,4,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1751,5,Myopathy,Myopathies,Muscle disorders,Musc,N
1751,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1751,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1752,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1753,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1753,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1753,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1754,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
1754,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1754,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1755,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1755,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1756,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
1756,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1756,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1756,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1757,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1758,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1758,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1759,1,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1759,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1759,3,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1759,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1759,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1760,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1760,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1760,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1761,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1761,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1762,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1763,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1764,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1764,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1764,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1764,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1764,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1765,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1765,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1765,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1766,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1766,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1767,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1767,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1768,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1768,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1769,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1769,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1770,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1770,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1770,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1771,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1771,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1772,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1773,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1774,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1774,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1775,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1776,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1777,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1778,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1779,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1780,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1781,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1781,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1782,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1782,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1782,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1782,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1783,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1784,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1784,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1784,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1785,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1785,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1785,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1786,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
1786,2,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1786,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1786,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1786,5,Intracranial haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1786,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1786,7,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1786,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1787,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1788,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1788,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1789,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
1789,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1789,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1790,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1791,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1792,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1793,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1794,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1794,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1795,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1796,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1796,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1797,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1797,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1798,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1799,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1799,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1800,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1801,1,Cerebellar haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1801,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1801,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1801,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1801,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1801,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1802,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1803,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1803,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1804,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1804,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1805,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1805,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1806,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1806,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1807,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1807,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1808,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1808,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1809,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1809,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1810,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1811,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1812,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1812,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1813,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1814,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1814,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1814,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1814,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1814,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1814,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1815,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1815,2,T-cell type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1815,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1816,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1817,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1817,2,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1817,3,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1817,4,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1817,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1817,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1818,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1818,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1818,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1818,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1819,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1820,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1821,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1821,2,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1821,3,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1821,4,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1821,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1821,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1822,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1822,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1823,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1823,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1823,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1823,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1823,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1824,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1825,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1825,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1826,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1827,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1827,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1827,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1827,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1827,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1827,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1827,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1827,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1828,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1829,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1830,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1830,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1830,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1831,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1832,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1833,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1834,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1835,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1835,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1835,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1836,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1837,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1837,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1838,1,Drug administered in wrong device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1838,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1839,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1839,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1839,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1840,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1840,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1841,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1841,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1842,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1842,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1842,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1843,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1843,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1844,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1844,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1844,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1844,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1844,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1844,6,Headache,Headaches NEC,Headaches,Nerv,N
1844,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1844,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1845,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1845,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1845,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1845,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1845,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1845,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1845,7,Headache,Headaches NEC,Headaches,Nerv,N
1845,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1846,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1846,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1846,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1846,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1847,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1847,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1847,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1847,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1847,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1847,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1847,7,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1848,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1848,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1848,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1848,4,Headache,Headaches NEC,Headaches,Nerv,N
1848,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1848,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1848,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1849,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1850,1,Cytology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1850,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1851,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1851,2,Unintentional use for unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1852,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1852,2,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1853,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1853,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1853,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1854,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1854,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1854,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1854,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1854,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1854,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1855,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1855,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1855,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1855,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1855,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1855,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1855,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1856,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1857,1,Cytology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1858,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1858,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1858,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1858,4,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1858,5,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1858,6,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1858,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1858,8,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1859,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
1859,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1859,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1859,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1859,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1860,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1861,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1861,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1861,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1861,4,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1862,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1862,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1863,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1864,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1864,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1865,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1865,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1866,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1867,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1867,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1867,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1868,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1868,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1869,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1870,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1870,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1870,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1870,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1871,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1872,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1872,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1872,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1873,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1874,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1874,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1875,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1875,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1875,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1875,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1876,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1876,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1877,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1878,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1879,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1879,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1879,3,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1879,4,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1879,5,Periodontal disease,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1879,6,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1879,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1879,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1879,9,Tooth deposit,Dental surface disorders,Dental and gingival conditions,Gastr,N
1880,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1880,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1880,3,Headache,Headaches NEC,Headaches,Nerv,N
1880,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1880,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1880,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1880,7,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1880,8,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1881,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1881,2,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1881,3,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1881,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1882,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1882,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1882,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1882,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1882,5,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
1882,6,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1882,7,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1883,1,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1883,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1883,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1883,4,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1883,5,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1883,6,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1883,7,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1884,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1884,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1884,3,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
1884,4,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1884,5,Low cardiac output syndrome,Heart failures NEC,Heart failures,Card,N
1884,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1884,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1884,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1884,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1884,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1885,1,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,Y
1885,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1885,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1886,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1886,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1886,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1886,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1887,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1887,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1887,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1887,4,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1887,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1887,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1888,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1888,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1889,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1889,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1889,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1889,4,Headache,Headaches NEC,Headaches,Nerv,N
1889,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1889,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1889,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1890,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1890,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1891,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1891,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1892,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1892,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1892,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1892,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1893,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1893,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1894,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1894,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1894,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1894,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1894,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1894,6,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
1894,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1895,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1895,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1895,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1895,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1895,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1896,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1896,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1897,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1897,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1897,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1897,4,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1898,1,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1898,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1898,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1898,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1898,5,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
1898,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1899,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1899,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1899,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1899,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1899,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1900,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1900,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1901,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1901,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1901,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1901,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1901,5,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1901,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1902,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
1903,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1903,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1903,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1903,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1903,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1903,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1904,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1904,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1904,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1905,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1906,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1907,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1908,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1909,1,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1909,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1910,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1910,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
1911,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1911,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1911,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1912,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1912,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1912,3,Early satiety,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1912,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1912,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1912,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1912,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1912,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1912,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1912,10,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1912,11,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
1912,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1912,13,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
1912,14,Serositis,Inflammations,General system disorders NEC,Genrl,N
1912,15,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1913,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1913,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1913,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1914,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1915,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1915,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1915,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1915,4,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,Y
1916,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1917,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1918,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1918,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1919,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1920,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1920,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1921,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1922,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1922,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1922,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1923,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1924,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1924,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1924,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1924,4,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1924,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1925,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1925,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1925,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1925,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1925,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1925,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1926,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1926,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1927,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1927,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1927,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1927,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1927,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1927,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1927,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1927,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1927,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1927,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1928,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1928,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1928,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1928,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1928,5,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1928,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1928,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1929,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1929,2,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1929,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1929,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1929,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1929,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1930,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1930,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1930,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1930,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1930,5,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1930,6,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1931,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1931,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
1931,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1932,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
1933,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1934,1,Cold type haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1934,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1934,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1934,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1934,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1935,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1936,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1936,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1936,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1936,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1937,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1937,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1937,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1937,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1938,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1938,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1939,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1939,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1939,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1939,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1939,5,Purpura fulminans,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1939,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1940,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1940,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1940,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1940,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1940,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1940,6,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1940,7,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1941,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1942,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1942,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1942,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1943,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1943,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1944,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1944,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1944,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1944,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1944,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1945,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1945,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1945,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1946,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1946,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1946,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1947,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1947,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1948,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1948,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1949,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1950,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1950,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1950,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1951,1,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1952,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1953,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1954,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1954,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1954,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1954,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1954,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1954,6,Rebound psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1954,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1954,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1954,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1955,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1955,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1956,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1956,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1957,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1958,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1959,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1960,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1960,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1960,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1961,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1961,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1961,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1961,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1961,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1962,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1963,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1963,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1964,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1964,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1965,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1965,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1965,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1965,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1965,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1965,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1966,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,4,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,5,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,6,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,7,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,8,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1966,9,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
1966,10,Pathological fracture,Fractures NEC,Fractures,Musc,N
1966,11,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1966,12,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1967,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1968,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1968,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1968,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1968,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1969,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1970,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1970,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1970,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1970,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1971,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1971,2,Migraine,Migraine headaches,Headaches,Nerv,N
1971,3,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1972,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1973,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1974,1,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1975,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1975,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1975,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1975,4,Headache,Headaches NEC,Headaches,Nerv,N
1975,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1975,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1975,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1976,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1976,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1976,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1976,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1976,5,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1977,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1977,2,Migraine,Migraine headaches,Headaches,Nerv,N
1977,3,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1978,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1978,2,Migraine,Migraine headaches,Headaches,Nerv,N
1978,3,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1979,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1980,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1980,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1980,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1980,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1980,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1980,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1980,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1980,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1980,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1980,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1981,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1981,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1982,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1982,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1982,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1983,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1984,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1985,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1985,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1985,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1986,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1986,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1987,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1988,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1988,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1988,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1989,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1989,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1990,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1991,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1992,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1992,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1992,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1993,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1994,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1995,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1996,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1996,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1996,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1997,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1997,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1997,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1998,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1999,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2000,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2000,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2000,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2001,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2001,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2001,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2002,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2002,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2002,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2002,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2002,5,Headache,Headaches NEC,Headaches,Nerv,N
2002,6,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2002,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2003,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2003,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2003,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2003,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2004,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
2004,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2004,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2004,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2004,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2004,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2004,7,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
2004,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2004,9,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2005,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2005,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2006,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2007,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2008,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2008,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2008,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2008,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2009,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2010,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2011,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2011,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2011,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2012,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2013,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2014,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
2014,2,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
2014,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
2014,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2014,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2015,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2016,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2017,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2018,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2019,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2020,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2021,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2022,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2023,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2023,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2023,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2023,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2024,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2025,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2025,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2025,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
2025,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2025,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2025,6,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2026,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2026,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2026,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
2027,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2028,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2029,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2030,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2031,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2031,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2032,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2033,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2033,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2033,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
2033,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2034,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2035,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2036,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2036,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2036,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2036,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2036,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2036,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2036,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2036,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2036,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2036,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2037,1,Ejection fraction abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2037,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2037,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2038,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2038,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2038,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2039,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2039,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2039,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2039,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2039,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2039,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2039,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2039,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2039,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2040,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2040,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2040,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2040,4,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
2040,5,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2041,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2041,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2042,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2042,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2042,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2043,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2043,2,Headache,Headaches NEC,Headaches,Nerv,N
2043,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2043,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2043,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2044,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2045,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2045,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2045,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2046,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2047,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2048,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2049,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2050,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2050,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2051,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2051,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2052,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2052,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
2052,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2052,4,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
2053,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2053,2,Migraine,Migraine headaches,Headaches,Nerv,N
2053,3,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2054,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2054,2,Pericardial disease,Pericardial disorders NEC,Pericardial disorders,Card,N
2055,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2055,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2056,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2056,2,Pericarditis constrictive,Noninfectious pericarditis,Pericardial disorders,Card,N
2057,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2057,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2057,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2057,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2058,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2058,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2058,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2058,4,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2058,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2058,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2058,7,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2059,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2060,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2061,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2062,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2063,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2064,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2065,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2066,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2067,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2068,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2069,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2070,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2071,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2072,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2073,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2074,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2075,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2076,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2077,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2078,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2079,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2080,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2081,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2082,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2083,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2084,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2085,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2086,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2087,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2088,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2089,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2090,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2091,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2092,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2093,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2094,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2095,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2096,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2097,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2098,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2099,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2100,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2101,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2102,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2103,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2104,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2105,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2106,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2107,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2108,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2109,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2110,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2111,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2112,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2113,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2114,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2115,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2116,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2117,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2118,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2119,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2120,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2121,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2122,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2123,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2124,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2125,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2126,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2127,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2128,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2129,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2130,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2131,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2132,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2133,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2134,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2135,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2136,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2137,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2138,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2139,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2140,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2141,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2142,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2143,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2144,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2145,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2146,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2147,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2148,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2149,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2150,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2151,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2152,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2153,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2154,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2155,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2156,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2157,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2158,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2159,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2160,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2161,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2162,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2163,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2164,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2165,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2166,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2167,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2168,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2169,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2170,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2171,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2172,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2173,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2174,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2175,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2176,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2177,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2178,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2179,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2180,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2181,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2182,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2183,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2184,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2185,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2186,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2187,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2188,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2189,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2190,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2191,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2192,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2193,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2194,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2195,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2196,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2197,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2198,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2199,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2199,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2199,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2199,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2199,5,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
2199,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2200,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2201,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2202,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2203,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2204,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2205,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2206,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2207,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2208,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2209,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2210,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2211,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2212,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2213,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2214,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2215,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2216,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2217,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2218,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2219,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2220,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2221,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2222,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2223,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2224,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2225,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2226,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2227,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2228,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2229,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2230,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2231,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2232,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2233,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2234,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2235,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2236,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2237,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2238,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2239,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2240,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2241,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2242,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2243,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2244,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2245,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2246,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2247,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2248,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2249,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2250,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2251,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2251,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2251,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2252,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2252,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2252,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2252,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2252,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2252,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2252,7,Headache,Headaches NEC,Headaches,Nerv,N
2252,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2252,9,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2252,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2252,11,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2252,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2252,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2252,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2252,15,Rectal prolapse,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
2252,16,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2252,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2253,1,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
2253,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2254,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2254,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2255,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2256,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2256,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2257,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2258,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2258,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2258,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2258,4,Placenta accreta,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
2258,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2259,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2259,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
2259,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2259,4,Positive airway pressure therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
2259,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2260,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2260,2,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
2260,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2261,1,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2262,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2263,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2264,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2265,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2265,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2265,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2265,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2265,5,Transfusion-related circulatory overload,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2265,6,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2266,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2266,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2267,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2268,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2268,2,Catheter site mass,Implant and catheter site reactions,Administration site reactions,Genrl,N
2268,3,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
2268,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2268,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2268,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2268,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2269,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2269,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2269,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2270,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2270,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2270,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2270,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
2270,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2270,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2271,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2271,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2271,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2271,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
2272,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2273,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
2274,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2274,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2274,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
2274,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2274,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2274,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2275,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2276,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2276,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2276,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2277,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2278,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2278,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2278,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2278,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2279,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2279,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2279,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2280,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2281,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2281,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2281,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2281,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2281,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2281,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
2281,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2281,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2281,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2281,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2281,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2281,12,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2281,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2281,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2282,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2282,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2282,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2283,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2283,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2283,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2284,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2284,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2284,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2284,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2285,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2286,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2287,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2287,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2287,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2287,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2287,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2287,6,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2288,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2288,2,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2289,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2290,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2290,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2290,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2290,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2291,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2292,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2293,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2294,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2294,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
2295,1,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2296,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2296,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2297,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2297,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2297,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2297,4,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2297,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2297,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2297,7,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2297,8,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2297,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2298,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2298,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2299,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2299,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2299,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2299,4,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2299,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2299,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2299,7,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2299,8,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2299,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2300,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2300,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2300,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2301,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2302,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
2302,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2302,3,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2302,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2302,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2302,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2302,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2302,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2303,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2304,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
2305,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2306,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2307,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2307,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2307,3,Headache,Headaches NEC,Headaches,Nerv,N
2307,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2307,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2307,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2307,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2308,1,Ovarian dysfunction,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
2308,2,Tooth agenesis,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
2309,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2310,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2310,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2310,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2310,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2311,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2312,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2312,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2313,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2314,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
2315,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2315,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2316,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2316,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2317,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2318,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
2319,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2320,1,Anti-glomerular basement membrane disease,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2320,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2320,3,Exposure to SARS-CoV-2,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
2320,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2321,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2321,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
2322,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2322,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
2323,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2324,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2325,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2325,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2325,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2325,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2325,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2325,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2326,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2326,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2327,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2327,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
2328,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2329,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2329,2,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
2330,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2330,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
2331,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2331,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2332,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
2333,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2334,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2335,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2336,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2337,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2338,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2338,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2339,1,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2339,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2339,3,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2340,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2340,2,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
2341,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2341,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2341,3,Headache,Headaches NEC,Headaches,Nerv,N
2341,4,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2341,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2341,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2341,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2342,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2343,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2344,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2344,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2344,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2344,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2344,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2344,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2345,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2345,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2345,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
2345,4,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2345,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2345,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2345,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2345,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2346,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2347,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2347,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2347,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2347,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2347,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2348,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2348,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2348,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2348,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2349,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2349,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2349,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2350,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2351,1,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
2351,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2352,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2352,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2352,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2353,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2354,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2354,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2354,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2355,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2355,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2355,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2356,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2357,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2358,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2359,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2359,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2359,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2360,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2360,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2360,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2360,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2360,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2361,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2361,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
2361,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2361,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2361,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2361,6,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
2361,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2361,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2361,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2361,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2361,11,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
2361,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2362,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2363,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2363,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2363,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2364,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2365,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2366,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2366,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2366,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2367,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2367,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2367,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2368,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2368,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2368,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2368,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2369,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2369,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2369,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2369,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2370,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2370,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2371,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2372,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2372,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2373,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2373,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2374,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2374,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2375,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2375,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2376,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2376,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2377,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2377,2,Headache,Headaches NEC,Headaches,Nerv,N
2377,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2377,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2378,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2378,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2378,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2378,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2378,5,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2378,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2378,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2379,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2379,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2379,3,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2379,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2379,5,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2380,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2380,2,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2381,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2381,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2382,1,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2382,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2383,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2383,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2383,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2383,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2383,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2383,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2383,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2383,8,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2383,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2383,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2383,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2383,12,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2383,13,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2383,14,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2383,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2384,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2384,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2385,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2385,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2385,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2386,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2386,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2387,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2388,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2389,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2390,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2391,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2391,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2391,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2391,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2391,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2391,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2392,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2392,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2392,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2392,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2392,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2393,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2394,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2395,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2396,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2396,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2397,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2398,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2399,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2399,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2400,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2400,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2400,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2401,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2401,2,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2401,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2401,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2401,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2401,6,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2401,7,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2401,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2402,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2402,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2402,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2402,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2403,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2404,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2404,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2404,3,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2405,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2405,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2405,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2405,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2406,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2407,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2407,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
2408,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2408,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2408,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2408,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2408,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2409,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2410,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2411,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2412,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2413,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2413,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2413,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2413,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2414,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2414,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2414,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2414,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2414,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2414,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2414,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2414,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2415,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2416,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2416,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2416,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2416,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2416,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2416,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2416,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2416,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2417,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2417,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2417,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2417,4,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2417,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2417,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2417,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2417,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2417,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2417,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2418,1,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
2418,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2419,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2419,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2419,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2419,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2419,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2419,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2419,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2419,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2419,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2419,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2419,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2419,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2419,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2419,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2419,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2419,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2420,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2420,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2420,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2420,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2420,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2420,6,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2421,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2421,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2422,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
2422,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2422,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2423,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2423,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2424,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2424,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2425,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2425,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2426,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2427,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2427,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2427,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2428,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2428,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2429,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2429,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2430,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2430,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2430,3,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2430,4,Oesophageal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2430,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2431,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2432,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2432,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2433,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2433,2,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
2434,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2435,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2435,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2435,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2435,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2435,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2435,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2436,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2436,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2436,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2436,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2436,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2436,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2436,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2436,8,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2436,9,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2436,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2436,11,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
2436,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2436,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2437,1,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
2437,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2437,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2438,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2439,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2440,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2440,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2440,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2441,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2442,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2442,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2443,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2443,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2444,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
2444,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2444,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2444,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2444,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2444,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2444,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2445,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2445,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2446,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2447,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2448,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2448,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2449,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2450,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2451,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2451,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2451,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2452,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2453,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2453,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2453,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2454,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2454,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2454,3,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2454,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2455,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2455,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2455,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2456,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2456,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2456,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
2456,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2456,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2457,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2457,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2457,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2457,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2458,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2458,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2459,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2460,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2461,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2462,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2463,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2463,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2463,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2464,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2465,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2465,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2466,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2466,2,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2467,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2468,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2469,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2469,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2469,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2469,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2469,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2470,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2471,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2472,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2473,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2474,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2475,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2475,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2475,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2475,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2475,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2475,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2475,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2475,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2475,9,Headache,Headaches NEC,Headaches,Nerv,N
2475,10,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2475,11,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
2475,12,Metastases to chest wall,Metastases to specified sites,Metastases,Neopl,N
2475,13,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2475,14,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
2475,15,Metastases to pancreas,Metastases to specified sites,Metastases,Neopl,N
2475,16,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2475,17,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2475,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2475,19,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
2475,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2475,21,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
2476,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2477,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2477,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2478,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2479,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2480,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2481,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2482,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2482,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2482,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2482,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
2482,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
2482,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2482,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2483,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2483,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2484,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2485,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2485,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2486,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2486,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2486,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2487,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2487,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2487,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2488,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2488,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2488,3,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
2489,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2489,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2489,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2489,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2489,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
2490,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2490,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2490,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2490,4,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
2490,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2491,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2491,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2491,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2491,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2492,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2492,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2492,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2493,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2494,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2495,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2496,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2496,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2496,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2497,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2498,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2499,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2499,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2500,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2501,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2501,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2502,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2502,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2502,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2502,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2502,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2502,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2502,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2503,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2504,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2505,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2505,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2506,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2507,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2508,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2509,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2510,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2511,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2511,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2512,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2512,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2513,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2513,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2513,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2514,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2514,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2514,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2514,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2515,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2516,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2516,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2517,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2518,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2518,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2518,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2519,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2519,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2519,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2519,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2521,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2521,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2522,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2522,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2522,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2522,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2523,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2523,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2524,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2524,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2524,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2524,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2524,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2524,6,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2524,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2524,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2524,9,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2524,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2524,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2524,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2524,13,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2524,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2524,15,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
2524,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2525,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2525,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
2526,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2527,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2527,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2527,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2527,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2527,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2527,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2527,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2527,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2528,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
2529,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
2530,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2530,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2531,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2531,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2532,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2532,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2533,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2534,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2535,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2535,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2536,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2537,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2538,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2538,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2538,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2539,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2540,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2540,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
2540,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2541,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2541,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2542,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2543,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2543,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2544,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2544,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2544,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
2544,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2544,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2544,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2544,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2544,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2544,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
2545,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2545,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2545,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2545,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2545,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2545,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2545,7,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2545,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2545,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2545,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2545,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2545,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2545,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2545,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2545,15,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2545,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2545,17,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2545,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2546,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2547,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2547,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2548,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2549,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2550,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2550,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2551,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2551,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2552,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2553,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2554,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2554,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2555,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2556,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2557,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2558,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2558,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2558,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2559,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2559,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2560,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2561,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2561,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2561,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2561,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2561,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2561,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2561,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2562,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2562,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2562,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2563,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2564,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2565,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2566,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2567,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2567,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2568,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2569,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2569,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2569,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2570,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2570,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2570,3,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2570,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2571,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2572,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2572,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2573,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2573,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2573,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
2573,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2574,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2575,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2576,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2576,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2577,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2577,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2577,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2578,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2578,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2578,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2579,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2579,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2580,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2581,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2581,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2581,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2582,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2583,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2584,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2585,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2585,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2585,3,Perineal necrosis,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
2585,4,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2585,5,Rectal perforation,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2586,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
2586,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2586,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2586,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2586,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2587,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2588,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2589,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
2590,1,Citrobacter bacteraemia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2590,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2590,3,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
2591,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2592,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2592,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2592,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2592,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2593,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2594,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2595,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2595,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2596,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2597,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2597,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2598,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2598,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2599,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2600,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2601,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2602,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
2602,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2602,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2603,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
2603,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2603,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2604,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2605,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2606,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2606,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2606,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2606,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2606,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2606,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2606,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2607,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2608,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2608,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2608,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2608,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2608,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2609,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2610,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2610,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2610,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2610,4,Tumour excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2611,1,Chronic myelomonocytic leukaemia,Myelodysplastic syndromes,Leukaemias,Neopl,N
2612,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2612,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2613,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2613,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2613,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2613,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2614,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
2614,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2614,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2614,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2614,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2614,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2614,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2615,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2615,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2616,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2616,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2617,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2617,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2618,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2618,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2619,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2619,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2619,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2619,4,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2619,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2620,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2621,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2622,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2622,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2622,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2623,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2624,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2625,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2625,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2625,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2626,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2626,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2627,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2627,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2627,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2628,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2629,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2629,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2629,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2630,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2630,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2630,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2631,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2631,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2631,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2631,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2631,5,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2631,6,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2631,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2631,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2631,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2632,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2632,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2634,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2634,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2634,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2634,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2634,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2635,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2635,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2635,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2635,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2636,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2636,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2637,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2637,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2637,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2638,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2638,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2638,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2639,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2639,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2640,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2641,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2641,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2642,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2642,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2642,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2643,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2643,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2643,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2643,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2643,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2643,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2643,7,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2643,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2643,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2643,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2643,11,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2643,12,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2643,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2643,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2643,15,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2643,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2643,17,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2643,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2643,19,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
2643,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2644,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2645,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2646,1,Aspiration bone marrow,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
2646,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2646,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2646,4,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2647,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2648,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2649,1,Drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2650,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2651,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2651,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2652,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2652,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2652,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2653,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2653,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2654,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2655,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2655,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2656,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2656,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2656,3,Blastocystis infection,Blastocystis infections,Protozoal infectious disorders,Infec,N
2656,4,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2656,5,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2656,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2656,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2656,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2657,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2657,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2658,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2658,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2658,3,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2658,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2658,5,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
2658,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2658,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2658,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2658,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2658,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2658,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2658,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2658,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2658,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2658,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2658,16,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2659,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2660,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2660,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2660,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2661,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2661,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2661,3,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2661,4,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2661,5,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2661,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2661,7,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
2661,8,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
2661,9,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2661,10,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2661,11,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2661,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2661,13,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2661,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2661,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2661,16,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2661,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2661,18,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2661,19,Viral haemorrhagic cystitis,Viral infections NEC,Viral infectious disorders,Infec,N
2662,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2663,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2663,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2664,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2665,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2666,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
2666,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2667,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2667,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2668,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2668,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2669,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2669,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2670,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2670,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2670,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2670,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2670,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2670,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2670,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2670,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2670,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2670,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2671,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2671,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2671,3,Blood antidiuretic hormone,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
2671,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2671,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2671,6,Headache,Headaches NEC,Headaches,Nerv,N
2671,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2671,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2671,9,Hypertensive emergency,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
2671,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2671,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2672,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
2673,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2674,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2674,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2675,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
2675,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2677,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2677,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2678,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2678,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2678,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2678,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2679,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2680,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2680,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2680,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2680,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2680,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2680,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2680,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2680,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2681,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2682,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2682,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2683,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2683,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2684,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2684,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2685,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2685,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2685,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2685,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2686,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2686,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2687,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2687,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2687,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2688,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2688,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2688,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2688,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2688,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2689,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2689,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2690,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2690,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2690,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
2690,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2690,5,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
2691,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2692,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2693,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2694,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2694,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2694,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2694,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2695,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2695,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2696,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2696,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2696,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2696,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2696,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2696,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2697,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2697,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2698,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2698,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2698,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2698,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2698,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2699,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2699,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2699,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2699,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2700,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2700,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2700,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2701,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2702,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2702,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2703,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2703,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
2704,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2704,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2705,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2705,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2706,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2707,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2708,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
2708,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2709,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2709,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2709,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2709,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2709,5,Headache,Headaches NEC,Headaches,Nerv,N
2709,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2709,7,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2709,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2709,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2709,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2709,11,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2709,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2709,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2709,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2710,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2710,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2711,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2711,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2711,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2712,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2712,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2713,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2713,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2714,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2714,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2714,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2715,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2715,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2716,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2716,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2717,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2718,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2718,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2719,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2719,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2719,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2720,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2720,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2720,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2720,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2720,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2720,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2720,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2720,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2720,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2720,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2720,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2720,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2720,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2721,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2721,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2722,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2723,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
2723,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2723,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2723,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2724,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2725,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2725,2,Respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
2726,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2726,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2726,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2726,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2727,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2727,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2727,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2727,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2728,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2729,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2729,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2730,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2730,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2730,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2730,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2730,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2730,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2731,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2731,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2731,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2731,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2731,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2731,6,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2731,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2731,8,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2731,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2732,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2732,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2732,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2732,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2732,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2732,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2732,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2733,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2733,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2733,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2733,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2733,5,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2734,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2734,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2735,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2735,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2735,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2735,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2736,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2736,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2737,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
2737,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2737,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2738,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2738,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
